| 4.86 0.09 (1.89%) | 06-09 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 5.93  |
1-year : | 6.93 |
| Resists | First : | 5.07 |
Second : | 5.93 |
| Pivot price | 4.14 |
|||
| Supports | First : | 3.64 |
Second : | 2.75 |
| MAs | MA(5) : | 4.43 |
MA(20) : | 4.12 |
| MA(100) : | 3.8 |
MA(250) : | 3.18 |
|
| MACD | MACD : | 0.2 |
Signal : | 0.1 |
| %K %D | K(14,3) : | 81.5 |
D(3) : | 72.7 |
| RSI | RSI(14): 66.5 |
|||
| 52-week | High : | 5.07 | Low : | 1.59 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ APYX ] has closed above the upper band by 5.5%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 42.6% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 0 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 5.08 - 5.1 | 5.1 - 5.11 |
| Low: | 4.6 - 4.62 | 4.62 - 4.64 |
| Close: | 4.83 - 4.86 | 4.86 - 4.88 |
Apyx Medical Corporation, an energy technology firm established in 1982 and headquartered in Clearwater, Florida, focuses on the development, manufacturing, and global sale of medical devices for both the aesthetic and surgical fields. The company operates through two main divisions: Advanced Energy and Original Equipment Manufacturing (OEM). Among its key innovations is the Helium Plasma Generator, which delivers a controlled combination of RF energy and helium to precisely cut, coagulate, and ablate soft tissue in open and laparoscopic surgical procedures. For the cosmetic surgery market, Apyx Medical offers its Renuvion product line, enabling plastic surgeons and other aesthetic practitioners to apply targeted heat for desired patient outcomes. Concurrently, the J-Plasma brand caters specifically to the hospital surgical sector. Furthermore, the company designs, produces, and sells disposable hand pieces, alongside OEM generators and their related accessories. The entity was previously known as Bovie Medical Corporation, changing its name to Apyx Medical Corporation in January 2019.
Mon, 01 Jun 2026
How The Apyx Medical (APYX) Story Is Shifting With AYON, GLP 1 Demand And 2026 Goals - Yahoo Finance
Wed, 27 May 2026
Real Renuvion patients hit the runway in Apyx’s Miami Swim Week show - Stock Titan
Wed, 27 May 2026
Body by Apyx Takes Center Stage at Miami Swim Week Showcasing Real Patient Transformations and Confidence on the Runway - PR Newswire
Thu, 21 May 2026
New Apyx Medical (APYX) data backs Avéli and Renuvion cellulite treatment - Stock Titan
Thu, 14 May 2026
Apyx Medical Corporation Announces Retrospective Clinical - GlobeNewswire
Mon, 11 May 2026
Apyx Medical Corporation (NASDAQ:APYX) Released Earnings Last Week And Analysts Lifted Their Price Target To US$6.50 - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 42 (M) |
| Shares Float | 29 (M) |
| Held by Insiders | 13.2 (%) |
| Held by Institutions | 49.5 (%) |
| Shares Short | 167 (K) |
| Shares Short P.Month | 196 (K) |
| EPS | -0.22 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.31 |
| Profit Margin | -16.4 % |
| Operating Margin | -7.3 % |
| Return on Assets (ttm) | -4.4 % |
| Return on Equity (ttm) | -76.5 % |
| Qtrly Rev. Growth | 32.5 % |
| Gross Profit (p.s.) | 0.84 |
| Sales Per Share | 1.33 |
| EBITDA (p.s.) | -0.09 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -8 (M) |
| Levered Free Cash Flow | -8 (M) |
| PE Ratio | -22.1 |
| PEG Ratio | 0.5 |
| Price to Book value | 15.67 |
| Price to Sales | 3.64 |
| Price to Cash Flow | -25.86 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|